| Literature DB >> 33224300 |
Viacheslav Petrov1, Rebecca J Dooley2, Alexander A Marchione2, Brittany S Clem2, William Marshall3, Elizabeth L Diaz3.
Abstract
Several new derivatives of adenine, purine, and theophylline containing the (CF3)2CH group connected to a nitrogen atom of the imidazole ring were prepared by the reaction of 2,2,4,4-tetrakis(trifluoromethyl)-1,3-dithietane (1) with the corresponding substrates, resulting in the selective alkylation of one of the nitrogen atoms of the imidazole ring. The reaction proceeds under mild conditions in a polar solvent, giving the alkylated products in 47-78% yield. While for purine and 4- and 5-azabenzimidazole, the reaction led to a mixture of two isomers, the reaction of adenine and the corresponding 2-fluoro derivative was regioselective, resulting in the formation of only one isomer in each case. The alkylation of theophylline led to the formation of a new derivative of caffeine.Entities:
Keywords: 2,2,4,4-tetrakis(trifluoromethyl)-1,3-dithietane; adenine; caffeine; cyclic dimer of hexafluorothioacetone; hexafluoroisopropyl group; purine; theophylline
Year: 2020 PMID: 33224300 PMCID: PMC7670113 DOI: 10.3762/bjoc.16.224
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Scheme 1Reaction of purine (2) with tetrakis(trifluoromethyl)-1,3-dithietane (1).
Figure 1Crystal structure of 2a, with the thermal ellipsoids drawn at 30% probability.
Scheme 2Reaction of 4-azabenzimidazole (3) with tetrakis(trifluoromethyl)-1,3-dithietane (1).
Scheme 3Reaction of 5-azabenzimidazole (4) with 1.
Scheme 4Reaction of adenine (5) and 2-fluoroadenine (6) with tetrakis(trifluoromethyl)-1,3-dithietane (1).
Scheme 5Reaction of theophylline (7) with tetrakis(trifluoromethyl)-1,3-dithietane (1).
Figure 2Crystal structure of 7a, with the thermal ellipsoids drawn at 30% probability.
Scheme 6Probable mechanism of the reaction of tetrakis(trifluoromethyl)-1,3-dithietane (1) with compounds 2–7.
Reaction products, conditions, yield, ratio of isomers, and melting points for the new materials.
| compound | solvent (cat.) | yield, % | ratio of isomers (crude product) | mp, °C (crude product) | mp, °C (recrystallized from hexane) | |
| DMSO | 25 (1) | 78 | 158–167 | – | ||
| DMSO | 25 (1) | 74 | 137–163 | |||
| DMSO | 25 (1) | 70 | – | |||
| DMSO | 25 (1) | 53 | one isomer | 212–214 | ||
| DMSO | 25 (1) | 66 | one isomer | – | ||
| DMF (CsF) | 25 (4) | 47 | 86–88 | |||
Enthalpy and entropy of activation for the rotameric interconversion of a subset of hexafluoroisopropyl azoles.
| compound | Δ | Δ | Δ | Δ | population of the major rotamer at 298 K |
| 11.6 | −5.38 | 11.1 | −5.90 | 0.691 | |
| 12.0 | −4.12 | 11.5 | −3.67 | 0.760 | |
| 11.6 | −5.91 | 10.6 | −7.76 | 0.680 | |
| 12.0 | −3.72 | 9.79 | −7.09 | 0.862 | |
Figure 3Top: 19F NMR spectra of 3a acquired over a sample temperature range of 223–373 K. Left: Fitted plot of integrated intensity vs interpulse delay time from the experiment inverting the minor rotamer of 3a at 253 K. Right: Eyring plot of the interconversion of the rotamers of 3a.
Figure 4DFT-optimized structures of the two rotamers of 3a. Left: Lower-energy rotamer. Right: Higher-energy rotamer.
NMR and MS data for the compounds 2a,b, 3a,b, 4a,b, 5a, 6a, and 7a,b.
| compound | 1H NMR (in CDCl3, δ, ppm; | 19F NMR (in CDCl3, δ, ppm; | 13C NMR (δ, ppm; | MS ( |
| 5.55 (1H, sept, 6.5), 8.40 (1H, s), 9.08 (1H, s), 9.28 (1H, s) | −68.75 (d, 6.6) | – | 270 (M+, C8H4F6N4+) | |
| 6.08 (1H, sept, 7.0), 8.33 (1H, s), 9.09 (1H, s), 9.30 (1H, s) | −69.75 (d, 7.0) | 55.07 (sept, 33.7), 120.51 (q, 283.8), 133.87, 141.75 (sept, 1.5), 149.83, 151.43, 153.80 | 270 (M+, C8H4F6N4+) | |
| 5.63 (1H, sept, 6.7), 7.40 (1H, dd, 8.4, 4.7), 7.89 (1H, d, 8.4), 8.37 (1H, s), 8.70 (1H, d, 4.7) | −68.95 (br. s, ∆√1/2 = 60 Hz) | 52.50 (br. s), 118.99, 119.61, 121.61 (q, 287.00), 144.00, 146.01, 159.81, 205.22 | 269 (M+, C9H5F6N3+) | |
| 6.18 (1H, sept), 7.40 (1H), | −69.95 (d, 6.9) | – | – | |
| 5.46 (sept, 6.7), 7.41 (1H, d, 5.7), 8.15 (1H, s), 8.61 (1H, d, 5.7), 9.24 (1H, s) | −69.15 (br. s) | 58.38 (sept, 32.8), 115.74, 120.78 (q, 284.4), 131.28, 132.90, 143.65, 144.00, 148.35 | 269 (M+, C9H5F6N3+) | |
| 5.46 (sept, 6.7), 7.41 (1H, d, 5.7), 8.15 (1H, s), 8.61 (1H, d, 5.7), 9.24 (1H, s) | −69.08 (br. s) | 58.10 (sept, 33.2), 104.64, 120.77 (q, 284.4), 138.78, 139.97, 142.11, 144.06, 144.09 | – | |
| 5.67 (2H, br. s), 5.95 (1H, sept, 7.2), 8.02 (1H, s), 8.48 (1H, s); | −69.08 (br. s, ∆√1/2 > 150 Hz); | 55.03 (sept, 33.0), 117.93, 121.44 (q, 282.0), 138.87, 150.41, 154.27, 156.20c | 285 (M+, C8H5F6N5+) | |
| 1.66 (1H, br. s), 5.81 (1H, sept, 7.2), 5.98 (1H, br. s), 7.98 (1H, s); | −69.84 (6F, br. s, ∆√1/2 = 50 Hz), −49.15 (1F, br. s); | 59.70 (sept, 32.0), 117.21, 121.51 (q, 283.8), 139.27, 151.88 (d, 20.4), 158.55 (d, 21.70), 159.68 (d, 205.9)c | 303 (M+, C8H4F7N5+) | |
| 3.40 (3H, s), 3.60 (3H, s), 6.74 (1H, sept, 7.0), 7.85 (1H, s) | −70.00 (d, 7.0) | – | 330 (M+, C10H8F6N4O2+) | |
| 3.39 (3H, s), 3.59 (3H, s), 4.68 (1H, sept, 7.8), 7.80 (1H, s) | −65.02 (d, 7.8) | – | – | |
a13C{1H} in CDCl3, unless stated otherwise. bMixture of isomers, solution in acetone. cIn DMSO-d6 as a solvent.